Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GPR120 agonists for the treatment of type II diabetes

GPR120 agonists for the treatment of type II diabetes

US Patent 10118922 · Granted Nov 6, 2018

Estimated economic value: $103,036,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyruvate kinase activators for use in treating blood disorders2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Inhibitors of cellular metabolic processes2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase modulators and use thereof2024
Pyruvate kinase activators for use in treating blood disorders2023
Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2022
Pyruvate kinase modulators and use thereof2022
Pyruvate kinase activators for use in treating blood disorders2022
Inhibitors of cellular metabolic processes2022
Account identifier digitization abstraction2022
Benzo-fused heterocyclic derivatives useful as agonists of GPR1202022